Expertise in
13
conditions

Pia Moinzadeh

University Of Cologne Kerpener Str
Koeln, NW, DE 
Expertise in
13
conditions
University Of Cologne Kerpener Str
Koeln, NW, DE 

Overview

Pia Moinzadeh practices practicing medicine in Koeln, Germany.

Ms. Moinzadeh is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Scleredema, and Localized Scleroderma.

She is actively involved in clinical research, co-authoring 66 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

University of Cologne Kerpener Str
Koeln, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Placebo-controlled Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Dupilumab in Localized Scleroderma
A Randomized, Placebo-controlled Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Dupilumab in Localized Scleroderma
Enrollment Status: Completed
Publish Date: October 26, 2024
Intervention Type: Drug, Other
Study Drug: Dupilumab
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 1 Less Clinical Trial

66 Total Publications

Does the RESIST score predict 5-year mortality beyond EUSTAR? Validation in the German Network for Systemic Sclerosis.
Does the RESIST score predict 5-year mortality beyond EUSTAR? Validation in the German Network for Systemic Sclerosis.
Journal: Annals of the rheumatic diseases
Published: July 08, 2026

Frequently Asked Questions about Pia Moinzadeh

Is Pia Moinzadeh a top-rated expert for Scleroderma?

MediFind is an objective health platform that identifies experts based on real-world data. Pia Moinzadeh is classified as an Elite expert for Scleroderma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pia Moinzadeh participate in research or clinical trials?

Yes. Pia Moinzadeh has published 66 articles and abstracts on conditions like Scleroderma. You can view a list of Pia Moinzadeh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Moinzadeh's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile